US Archives - Page 41 of 165 - European Medical Journal

How Advances Across Eras Are Reshaping Pancreatic Cancer Outcomes

Advances in early detection, prevention, and treatment are reshaping the outlook for pancreatic cancer, one of the deadliest malignancies worldwide.

Gut-Brain Benefits of Oolong Tea in Autism

Oolong tea may reduce neuroinflammation by modulating the microbiota-gut-brain axis, according to findings from a rat model of autism.

Study Finds Adults Drive More Tuberculosis Transmission

Youth aged 15–24 years play a smaller role in spreading tuberculosis (TB) within households compared to adults, according to a new study.

Managing Asthma During Puberty, Pregnancy, and Menopause

Asthma management in women requires tailored approaches across puberty, pregnancy, and menopause, as each life stage introduces unique challenges that influence symptoms, adherence, and outcomes.

Non-Drug Strategies Ease Pain and Fatigue in Scleroderma

Pain and fatigue are among the most disabling symptoms in systemic sclerosis, and new evidence highlights the promise of non-drug strategies to ease their impact on daily life.

A Step Forward Against Chronic Kidney Disease Itch

Dupilumab may provide meaningful relief for patients with chronic kidney disease who experience uremic pruritus and for those with atopic dermatitis complicated by renal impairment, according to a retrospective real-world study.

Survival Clues from Necrotising Lung Infections in Critical Care

Necrotising lung infections (NLI) significantly affect the course and outcomes of patients requiring veno-venous extracorporeal membrane oxygenation (VV-ECMO).

Exploring the Effect of Parkinson’s Therapies on Vision

Visual symptoms in Parkinson’s disease may remain largely unchanged despite treatment with levodopa or deep brain stimulation.

Folinic Acid Combination May Help Extend Options in Pancreatic Cancer

Patients with unresectable pancreatic cancer who receive second-line treatment with nanoliposomal irinotecan in combination with fluorouracil and folinic acid may remain eligible for subsequent third-line chemotherapy.

Hidden Threats: Donor-Derived Infections in Heart and Lung Transplants

Donor-derived infections are a significant concern for heart and lung transplant recipients, with established and emerging pathogens creating complex challenges for post-transplant care, according to new research.